Intravenous therapy for advanced heart failure.

Area of Science:

• Cardiology
• Pharmacology

Background:

• Oral neurohumoral antagonists are standard for heart failure.
• The role of intravenous agents has significantly evolved.

Purpose of the Study:

• To define the current indications for intravenous agents in advanced heart failure.
• To clarify their use in specific patient populations.

Main Methods:

• Review of current clinical practice guidelines.
• Analysis of patient data for advanced heart failure management.

Main Results:

• Intravenous agents are used short-term for decompensated New York Heart Association class IV patients requiring hemodynamic support.
• Long-term intravenous agent use is indicated for heart transplant candidates with advanced, refractory heart failure.

Conclusions:

• The application of intravenous agents in advanced heart failure is now highly specialized.
• These agents serve critical roles in acute decompensation and as a bridge to transplantation.